Evaluation items (10) | Subitems (39) | Definition/note |
---|---|---|
Clarity | ||
 | Clear purposes | The hypothesis is clear in each aspect (i.e., subitems), evaluated on a 5-point Likert scale |
 | Clear, focused groups | |
 | Specified variables | |
 | Specified relationships among variables | |
 | Overall clear | |
Clinical relevance | ||
 | Impact on current clinical practice | To test if the hypothesis has the potential to have a significant impact on each of these aspects (i.e., subitems), evaluated on a 5-point Likert scale |
 | Impact medical knowledge | |
 | Impact health policy | |
 | Overall clinically relevant | |
Ethicality | ||
 | No ethical concerns | When conducting a study to test a given hypothesis, there are no ethical concerns (regarding stakeholders and conduction). Consider using binary options instead of a 5-point Likert scale |
 | Trade my place with a participant if eligible | |
 | Overall, an ethical study to test | |
Feasibility | ||
 | Regarding needed costs | To test if the hypothesis is feasible regarding the available resources and scope of the work, evaluated on a 5-point Likert scale |
 | Regarding needed time | |
 | Regarding the scope of the work | |
 | Overall feasible | |
Interestingness | ||
 | It interests me | The researcher should be able to find interested collaborators easily in the field; consider using binary options instead of a 5-point Likert scale |
 | I will pursue it if possible. | |
 | Overall an interesting idea | |
Novelty | ||
 | Leads to innovation in medical practice | To test if the hypothesis has the potential to lead to innovations in each of these aspects (i.e., subitems), evaluated on a 5-point Likert scale |
 | This leads to new methodologies for clinical research | |
 | It may alter previous findings | |
 | Leads to novel medical knowledge | |
 | This leads to new findings, which can be incremental | |
 | Overall novel | |
Potential benefits and risks | ||
 | Significant benefits | To test if the hypothesis has the potential to provide significant benefits over risks to stakeholders; consider using binary options instead of a 5-point Likert scale |
 | No or tolerable risks | |
 | The overall benefits outweigh the risks | |
Significance | ||
 | Addressing established medical needs | To test if the hypothesis has the potential to have an impact on each of these aspects (i.e., subitems), evaluated on a 5-point Likert scale |
 | Impact future direction of the field | |
 | Impact on the target population | |
 | Impact the cost and benefit | |
 | Overall significant | |
Testability | ||
 | It can be tested in an ideal setting | The hypothesis can be tested, regardless of feasibility, and evaluated on a 5-point Likert scale |
 | Adequate number of patients to choose from | |
 | Overall testable | |
Validity | ||
 | Scientific validity | The hypothesis is scientifically and clinically valid, evaluated on a 5-point Likert scale |
 | Clinical validity | |
 | Overall valid |